Skip to content

3 Best Drug Stocks to Watch in 2024

3 Best Drug Stocks to Watch in 2023
Diana Paluteder

Summary: With the pharmaceutical industry’s worth measured in trillions, it’s no wonder that investors worldwide are eager to tap into its remarkable growth potential. In this guide, we’ll unveil the 3 best drug stocks to watch in 2024, accessible with popular online stock brokerages like Interactive Brokers and eToro.

Highly Rated Stock Trading & Investing Platform

  • Invest in 2,800+ stocks and other assets including 70+ cryptocurrencies and commodities.

  • 0% commission on buying stocks - buy in bulk or just a fraction from as little as $10.

  • Copy top-performing traders in real time, automatically.

  • Regulated by financial authorities including FCA and FINRA.

2.8 Million Users
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. eToro USA LLC does not offer CFDs, only real Crypto assets available. Don’t invest unless you’re prepared to lose all the money you invest.

What are drug stocks?

Investing in the pharmaceutical industry – what to consider

Here are some key considerations when investing in the pharma industry:

  • Pipeline and product portfolio: Assess the pharmaceutical company’s product pipeline. Look for a diversified portfolio of drugs, including potential blockbuster drugs. Evaluate the stage of development and the potential market impact of these drugs;
  • Regulatory environment: Understand the regulatory landscape. Regulatory approvals from agencies like the FDA (U.S.) or EMA (Europe) can significantly impact a pharmaceutical company’s success. Keep an eye on regulatory changes and any pending approvals;
  • Intellectual property: Check the company’s patent portfolio. Patents protect a drug’s exclusivity; when they expire, generic competition can reduce profits. Know when key patents are set to expire and how the company plans to address it;
  • Clinical trial results: Investigate the results of ongoing and completed clinical trials. Positive outcomes can boost stock prices, while negative results can have the opposite effect. Understand the risks associated with clinical trials;
  • Market competition: Analyze the competitive landscape. Identify other companies with similar drug portfolios and assess their market positions and competitive advantages;
  • Revenue and earnings growth: Review the company’s financials, focusing on revenue and earnings growth over the years. Consistent growth is a positive sign;
  • Dividends and share buybacks: Some pharmaceutical companies offer dividends and engage in share buybacks. These can provide additional returns to investors;
  • Research and development (R&D) investment: Look at the company’s commitment to R&D. A robust R&D pipeline is vital for long-term success in the industry;
  • Market trends: Stay updated on healthcare and pharmaceutical industry trends, such as personalized medicine, biotechnology advancements, and shifts in global healthcare policies;
  • Global reach: Consider a company’s international presence. Expanding into emerging markets can be a growth opportunity;
  • Risk management: Be aware of potential risks, including legal challenges (e.g., patent disputes), pricing pressures, and adverse events related to drugs in the market;
  • Management team: Assess the leadership team’s experience and track record in the pharmaceutical industry. Strong management can navigate challenges effectively;
  • Valuation: Evaluate the company’s valuation metrics, such as price-to-earnings (P/E) ratio and price-to-sales (P/S) ratio, in comparison to industry peers;
  • Diversification: If you’re building a pharmaceutical portfolio, consider diversifying across companies with different risk profiles and areas of expertise;
  • Long-term perspective: Pharma investments often require a long-term horizon. Be prepared for potential volatility and fluctuations in stock prices.

3 best drug stocks to watch in 2024

Now that you have gained a deeper understanding of the factors to consider when contemplating an investment in the pharmaceutical industry or big pharma, you are well-equipped to confidently embark on your investment journey. 

Here are our picks for the 3 best drug stocks at the forefront of innovation and healthcare advancements:

You may also wish to explore disease-focused stocks for a specialized approach within the pharmaceutical sector. Explore these guides for a comprehensive analysis of investment opportunities centered around particular medical conditions:

To securely invest in the pharmaceutical sector, consider these brokers:

1. eToro

  • Commission-free stock trading; 
  • 2,000+ stocks from 17 exchanges;
  • Fractional shares available;
  • User-friendly platform.

Highly Rated Stock Trading & Investing Platform

  • Invest in 2,800+ stocks and other assets including 70+ cryptocurrencies and commodities.

  • 0% commission on buying stocks - buy in bulk or just a fraction from as little as $10.

  • Copy top-performing traders in real time, automatically.

  • Regulated by financial authorities including FCA and FINRA.

2.8 Million Users
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. eToro USA LLC does not offer CFDs, only real Crypto assets available. Don’t invest unless you’re prepared to lose all the money you invest.

2. Interactive Brokers (IBKR)

  • Commission-free stock trading;
  • Global stock-trading on 90+ market centers;
  • Fractional shares available;
  • Extra income on fully paid shares;
  • Lowest financing rates for margin accounts in the industry;
  • No account minimum. 

Best Platform for Worldwide Stock Trading & Investing

  • Highly trusted multi-asset broker with clients in over 200 countries

  • Trade on 150 markets globally from a single platform (stocks, ETFs, futures, currencies, crypto & more)

  • Low commissions starting at $0 with no platform fees or account minimums

  • Easily fund your account and trade assets in 26 currencies

  • IBKR pays up to 4.58% interest on cash balances of $10k or more

Up to 4.58% interest on balance*

Now, let’s dive in deeper. 

Best drug stocks to watch in 2024 #1: AbbVie 

2023 Q3 Market Capitalization: $270.9B 

2022 Revenue: $58.1B

2022 Earnings: $11.8B

AbbVie Inc. (NYSE: ABBV) is an American pharmaceutical company focusing on the research and development of various therapeutic areas, including immunology, oncology, neuroscience, and more. A standout product in AbbVie’s portfolio is Humira (adalimumab), approved for treating autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, plaque psoriasis, and ulcerative colitis. 

AbbVie’s innovative approach to addressing complex medical conditions, coupled with its robust revenue stream and consistent dividends, positions it as an enticing prospect for pharmaceutical sector investors.

AbbVie is publicly listed on the New York Stock Exchange (NYSE) under the stock ticker ABBV and is a component of the S&P 100 and S&P 500. 

AbbVie stock price today

Best drug stocks to watch in 2024 #2: Pfizer

2023 Q3 Market capitalization: $191.9B 

2022 Revenue: $100.3B

2022 Earnings: $31.4B

Pfizer Inc. (NYSE: PFE) is a globally recognized American pharmaceutical corporation headquartered in New York City, New York. The company’s research efforts encompass a wide spectrum of healthcare areas, including vaccines, oncology, cardiology, and infectious diseases. Notably, Pfizer has been at the forefront of the fight against global health crises, such as developing the first authorized COVID-19 vaccine.

Pfizer is publicly listed on the New York Stock Exchange (NYSE) under the stock ticker PFE and is a constituent of the S&P 100 and the S&P 500.

Pfizer stock price today

Best drug stocks to watch in 2024 #3: Johnson & Johnson

2023 Q3 Market capitalization: $390.6B

2022 Revenue: $94.9B

2022 Earnings: $17.9B

Johnson & Johnson (NYSE: JNJ) is a globally renowned American multinational corporation with a rich legacy in pharmaceuticals, medical technologies, and consumer health products. Johnson & Johnson’s impact on healthcare is far-reaching. The company’s pharmaceutical division has been responsible for pioneering groundbreaking medications, medical devices, and healthcare solutions that have transformed countless lives. Simultaneously, its consumer health products have earned the trust of consumers worldwide, making Johnson & Johnson a household name synonymous with quality and reliability.

Johnson & Johnson is publicly listed on the New York Stock Exchange (NYSE) under the stock ticker JNJ and is a component of major stock indices like the Dow Jones Industrial Average (DJIA), the S&P 100, and the S&P 500.

Johnson & Johnson stock price today

Risks of investing in the pharmaceutical industry

Investing in pharmaceutical stocks entails a range of risks beyond regulatory approval challenges, including:

  • Increased generic competition: Growing competition from generic drugs can reduce market share and profit margins;
  • Product liability and legal risks: The medical risks tied to pharmaceutical products expose companies to product liability and legal issues. Safety concerns can lead to drug recalls, and pharmaceutical companies frequently contend with litigation;
  • Necessary technological innovations: Constant technological advancements are required to maintain competitiveness;
  • Counterfeit drugs and quality control: Ensuring the quality and authenticity of pharmaceutical products is crucial to reputation and safety;
  • Reimbursement challenges: To ensure the commercial success of approved drugs, pharmaceutical firms must navigate the complexities of securing reimbursement from institutional payers, such as public and private health insurers, who often exert pressure to set drug prices lower than desired targets;
  • Patent expirations: When patents expire, sales of previously lucrative products can plummet, impacting revenue significantly.

Navigating these risks involves careful research, diversification, and monitoring industry developments to make informed investment decisions.

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk. 

FAQs about drug stocks

What drug stocks to buy now?

Notable players in the pharmaceutical drug arena include Pfizer, Johnson & Johnson, and AbbVie. 

Where to buy drug stocks?

You can invest in drug stocks via regulated online brokers like Interactive Brokers and eToro. 

How to invest in drug stocks?

To invest in drug stocks, choose a reputable online broker, create an account, deposit funds, search for your desired drug company by their ticker symbol, determine your investment amount and order type, and complete your purchase.

Are drug stocks a good investment?

Drug stocks often appeal to income-focused investors due to their potential for attractive dividends. Yet, the substantial expenses and extended timelines from drug discovery to approval underscore the inherent risks of investing in this sector.

Highly Rated Stock Trading & Investing Platform

  • Invest in 2,800+ stocks and other assets including 70+ cryptocurrencies and commodities.

  • 0% commission on buying stocks - buy in bulk or just a fraction from as little as $10.

  • Copy top-performing traders in real time, automatically.

  • Regulated by financial authorities including FCA and FINRA.

2.8 Million Users
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. eToro USA LLC does not offer CFDs, only real Crypto assets available. Don’t invest unless you’re prepared to lose all the money you invest.

Weekly Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related guides

Contents